1. Home
  2. ROKU vs ROIV Comparison

ROKU vs ROIV Comparison

Compare ROKU & ROIV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ROKU
  • ROIV
  • Stock Information
  • Founded
  • ROKU 2002
  • ROIV 2014
  • Country
  • ROKU United States
  • ROIV United Kingdom
  • Employees
  • ROKU N/A
  • ROIV N/A
  • Industry
  • ROKU Cable & Other Pay Television Services
  • ROIV Biotechnology: Pharmaceutical Preparations
  • Sector
  • ROKU Telecommunications
  • ROIV Health Care
  • Exchange
  • ROKU Nasdaq
  • ROIV Nasdaq
  • Market Cap
  • ROKU 10.8B
  • ROIV 8.4B
  • IPO Year
  • ROKU 2017
  • ROIV N/A
  • Fundamental
  • Price
  • ROKU $79.00
  • ROIV $11.82
  • Analyst Decision
  • ROKU Buy
  • ROIV Strong Buy
  • Analyst Count
  • ROKU 22
  • ROIV 10
  • Target Price
  • ROKU $81.48
  • ROIV $17.39
  • AVG Volume (30 Days)
  • ROKU 2.4M
  • ROIV 4.0M
  • Earning Date
  • ROKU 10-30-2024
  • ROIV 11-11-2024
  • Dividend Yield
  • ROKU N/A
  • ROIV N/A
  • EPS Growth
  • ROKU N/A
  • ROIV N/A
  • EPS
  • ROKU N/A
  • ROIV 5.65
  • Revenue
  • ROKU $3,746,091,000.00
  • ROIV $158,303,000.00
  • Revenue This Year
  • ROKU $15.79
  • ROIV $53.59
  • Revenue Next Year
  • ROKU $13.01
  • ROIV $26.91
  • P/E Ratio
  • ROKU N/A
  • ROIV $2.05
  • Revenue Growth
  • ROKU 16.46
  • ROIV 101.44
  • 52 Week Low
  • ROKU $48.33
  • ROIV $8.29
  • 52 Week High
  • ROKU $108.84
  • ROIV $13.06
  • Technical
  • Relative Strength Index (RSI)
  • ROKU 55.25
  • ROIV 47.60
  • Support Level
  • ROKU $75.06
  • ROIV $11.52
  • Resistance Level
  • ROKU $77.25
  • ROIV $12.08
  • Average True Range (ATR)
  • ROKU 2.28
  • ROIV 0.22
  • MACD
  • ROKU -0.42
  • ROIV -0.01
  • Stochastic Oscillator
  • ROKU 54.91
  • ROIV 29.40

About ROKU Roku Inc.

Roku enables consumers to stream television programming. It has more than 80 million streaming households and provided well over 100 billion streaming hours in 2023. Roku is the top streaming operating system in the US, reaching more than half of broadband households, according to the company. Roku's OS is built into streaming devices and televisions that Roku sells and on connected televisions from other manufacturers that license Roku's name and software. Roku also operates the Roku Channel, a free, ad-supported streaming television platform that offers a mix of on-demand and live television programming. Roku generates revenue primarily from selling devices, licensing, and advertising, and it receives fees from subscription streaming platforms that sell subscriptions through Roku.

About ROIV Roivant Sciences Ltd.

Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.

Share on Social Networks: